Lpl Financial LLC Bio Rad Laboratories, Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 3,869 shares of BIO stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,869
Previous 3,342 15.77%
Holding current value
$1.29 Million
Previous $912,000 41.89%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$263.97 - $344.64 $139,112 - $181,625
527 Added 15.77%
3,869 $1.29 Million
Q2 2024

Aug 07, 2024
SELL
$268.26 - $339.48 $190,732 - $241,370
-711 Reduced 17.54%
3,342 $912,000
Q1 2024

May 10, 2024
SELL
$304.11 - $351.99 $6.34 Million - $7.34 Million
-20,864 Reduced 83.73%
4,053 $1.4 Million
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $2 Million - $2.71 Million
-7,420 Reduced 22.95%
24,917 $8.05 Million
Q3 2023

Nov 13, 2023
BUY
$350.25 - $422.63 $520,471 - $628,028
1,486 Added 4.82%
32,337 $11.6 Million
Q2 2023

Jul 31, 2023
BUY
$359.49 - $486.4 $575,184 - $778,240
1,600 Added 5.47%
30,851 $11.7 Million
Q1 2023

May 10, 2023
BUY
$418.69 - $503.0 $556,020 - $667,984
1,328 Added 4.76%
29,251 $14 Million
Q4 2022

Feb 07, 2023
SELL
$351.71 - $456.01 $21,454 - $27,816
-61 Reduced 0.22%
27,923 $11.7 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $661,794 - $903,469
1,604 Added 6.08%
27,984 $11.7 Million
Q2 2022

Aug 12, 2022
BUY
$463.67 - $597.16 $745,117 - $959,636
1,607 Added 6.49%
26,380 $13.1 Million
Q1 2022

May 16, 2022
BUY
$524.57 - $735.42 $419,131 - $587,600
799 Added 3.33%
24,773 $14 Million
Q4 2021

Feb 14, 2022
BUY
$708.84 - $794.68 $2.12 Million - $2.37 Million
2,986 Added 14.23%
23,974 $18.1 Million
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $615,616 - $772,920
-936 Reduced 4.27%
20,988 $15.7 Million
Q2 2021

Aug 13, 2021
BUY
$576.64 - $649.04 $1.02 Million - $1.14 Million
1,762 Added 8.74%
21,924 $14.1 Million
Q1 2021

May 14, 2021
BUY
$547.01 - $662.35 $1.59 Million - $1.93 Million
2,915 Added 16.9%
20,162 $11.5 Million
Q4 2020

Feb 12, 2021
BUY
$510.68 - $643.45 $1.35 Million - $1.7 Million
2,637 Added 18.05%
17,247 $10.1 Million
Q3 2020

Nov 09, 2020
BUY
$454.43 - $535.6 $881,594 - $1.04 Million
1,940 Added 15.31%
14,610 $7.53 Million
Q2 2020

Aug 13, 2020
BUY
$334.87 - $493.06 $827,798 - $1.22 Million
2,472 Added 24.24%
12,670 $5.72 Million
Q1 2020

May 14, 2020
BUY
$320.01 - $409.07 $262,408 - $335,437
820 Added 8.74%
10,198 $3.58 Million
Q4 2019

Feb 14, 2020
BUY
$319.73 - $374.2 $311,097 - $364,096
973 Added 11.58%
9,378 $3.47 Million
Q3 2019

Nov 13, 2019
BUY
$304.55 - $345.24 $210,444 - $238,560
691 Added 8.96%
8,405 $2.8 Million
Q2 2019

Aug 09, 2019
BUY
$286.93 - $312.59 $505,857 - $551,096
1,763 Added 29.63%
7,714 $2.41 Million
Q1 2019

May 08, 2019
BUY
$224.3 - $317.41 $216,673 - $306,618
966 Added 19.38%
5,951 $1.82 Million
Q4 2018

Feb 07, 2019
BUY
$220.1 - $309.0 $130,079 - $182,619
591 Added 13.45%
4,985 $1.16 Million
Q3 2018

Nov 14, 2018
BUY
$289.28 - $326.15 $150,136 - $169,271
519 Added 13.39%
4,394 $1.38 Million
Q2 2018

Aug 14, 2018
SELL
$244.1 - $303.88 $138,648 - $172,603
-568 Reduced 12.78%
3,875 $1.12 Million
Q1 2018

May 15, 2018
BUY
$233.97 - $274.11 $251,283 - $294,394
1,074 Added 31.88%
4,443 $1.11 Million
Q4 2017

Feb 14, 2018
BUY
$216.94 - $271.3 $14,751 - $18,448
68 Added 2.06%
3,369 $804,000
Q3 2017

Nov 14, 2017
BUY
$212.27 - $242.28 $700,703 - $799,766
3,301
3,301 $734,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email